智通财经APP讯,药明生物(02269)发布公告,于2025年3月26日,其已批准授出合共2552.09万股受限制股份奖励计划受限制股份,但须根据受限制股份奖励计划待受限制股份奖励计划承授人接纳,方可作实。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.